NVDA vs AVGO vs MU
161 measures in 16 categories, one definition each, computed from filings and market data.
Price, rebased to 100 three years ago
NVDA AVGO MU · weekly adjusted closesSmart money 8Valuation 16Profitability (TTM) 12Returns on capital 11Growth 17Margin history & stability 7Liquidity (latest quarter) 7Leverage & solvency (latest quarter) 13Efficiency 11Cash flow & earnings quality 7Dividends & buybacks 9Scores & forensic checks 15Per share 7Size (TTM) 8Price performance 9Technicals 4
● marks the highest or lowest value where that direction is plainly stronger (margins, returns, coverage, leverage); multiples and yields are left unmarked. Bars show each stock's percentile within its own industry. n/a: the measure does not apply to lenders and insurers.
Smart money
8 measures| Measure | NVDA | AVGO | MU |
|---|---|---|---|
| Insider open-market buys, 180d | 0 | 1 | 0 |
| Insider $ bought, 180d | — | $0.37M | — |
| Congress purchases, 180d | 19 | 14 | 11 |
| Last Congress purchase | 2026-09-23 | 2026-08-26 | 2026-07-10 |
| 13F net change in holders | +122 | +159 | +900 |
| ETFs adding shares, 30d | 3,025 | 2,686 | 2,284 |
| ETFs trimming, 30d | 2,646 | 1,911 | 2,169 |
| Net ETF funds, 30d | +379 | +775 | +115 |
Valuation
16 measures| Measure | NVDA | AVGO | MU |
|---|---|---|---|
| P/E (TTM) | 26.8x
22nd
|
41.0x
35th
|
11.7x
2nd
|
| PEG (P/E ÷ 3-yr EPS CAGR) | 0.16
0th
|
1.21
22nd
|
— |
| Price / sales | 17.0x
80th
|
17.6x
83rd
|
7.5x
48th
|
| Price / book | 22.5x
92nd
|
15.7x
88th
|
7.2x
65th
|
| Price / tangible book | 24.5x
79th
|
— | 8.0x
43rd
|
| Price / free cash flow | 40.6x
35th
|
39.8x
33rd
|
18.8x
9th
|
| Price / operating cash flow | 38.4x
47th
|
38.6x
48th
|
11.1x
5th
|
| Enterprise value | $5.10T
100th
|
$1.60T
99th
|
$956.1B
97th
|
| EV / sales | 16.8x
81st
|
18.0x
85th
|
7.2x
47th
|
| EV / EBITDA | 21.8x
30th
|
30.7x
54th
|
8.7x
7th
|
| EV / EBIT | 22.2x
21st
|
36.9x
43rd
|
9.6x
8th
|
| EV / free cash flow | 40.2x
28th
|
40.7x
33rd
|
18.1x
6th
|
| Earnings yield | 3.7%
85th
|
2.4%
76th
|
8.5%
99th
|
| FCF yield | 2.5%
75th
|
2.5%
76th
|
5.3%
93rd
|
| Operating cash flow yield | 2.6%
64th
|
2.6%
63rd
|
9.0%
96th
|
| Graham number (per share) | $41.05
67th
|
$59.95
81st
|
$448.43
100th
|
Profitability (TTM)
12 measures| Measure | NVDA | AVGO | MU |
|---|---|---|---|
| Gross margin | 74.7%
91st
|
68.8%
89th
|
80.7%
96th
|
| EBITDA margin | 77.2%
99th
|
58.7%
96th
|
82.1%
100th
|
| Operating margin | 65.2%
99th
|
48.4%
96th
|
75.0%
100th
|
| EBIT margin | 76.0%
100th
|
48.9%
96th
|
75.0%
99th
|
| Net margin | 63.7%
99th
|
42.9%
96th
|
63.8%
100th
|
| NOPAT margin | 54.7%
99th
|
45.7%
96th
|
63.9%
100th
|
| FCF margin | 41.9%
97th
|
44.2%
99th
|
39.7%
96th
|
| Operating cash flow margin | 44.3%
93rd
|
45.6%
96th
|
67.3%
100th
|
| R&D / revenue | 7.8%
16th
|
13.3%
37th
|
4.2%
8th
|
| SG&A / revenue | 1.7%
3rd
|
4.7%
4th
|
1.5%
1st
|
| Stock comp / revenue | 2.4%
34th
|
9.5%
73rd
|
1.0%
14th
|
| Effective tax rate | 16.0%
44th
|
5.4%
11th
|
14.8%
36th
|
Returns on capital
11 measures| Measure | NVDA | AVGO | MU |
|---|---|---|---|
| ROE (on average equity) | 117.2%
100th
|
44.2%
95th
|
88.3%
99th
|
| ROA | 83.7%
100th
|
21.6%
87th
|
61.0%
99th
|
| ROIC | 98.5%
99th
|
30.2%
83rd
|
85.0%
97th
|
| ROCE | 83.0%
100th
|
26.0%
89th
|
59.3%
99th
|
| Return on tangible assets | 99.9%
100th
|
24.6%
88th
|
71.7%
99th
|
| Cash ROIC (OCF / invested capital) | 79.8%
99th
|
30.1%
74th
|
89.6%
100th
|
| Gross profitability (GP / assets) | 70.6%
100th
|
32.3%
69th
|
54.9%
99th
|
| ROIC, 3-yr average | — | 17.3%
71st
|
40.1%
91st
|
| ROIC, 5-yr average | 128.9%
95th
|
23.2%
67th
|
23.3%
68th
|
| ROE, 5-yr average | 66.4%
98th
|
36.7%
91st
|
16.6%
66th
|
| Incremental ROIC | 59.3%
76th
|
105.8%
85th
|
105.0%
83rd
|
Growth
17 measures| Measure | NVDA | AVGO | MU |
|---|---|---|---|
| Revenue growth (TTM YoY) | 83.4%
95th
|
48.7%
84th
|
256.3%
99th
|
| Revenue growth (QoQ) | 17.9%
67th
|
33.4%
88th
|
30.8%
85th
|
| Revenue CAGR, 3 yr | 110.1%
100th
|
36.0%
93rd
|
104.6%
97th
|
| Revenue CAGR, 5 yr | 69.1%
100th
|
27.4%
86th
|
36.9%
91st
|
| Gross profit CAGR, 3 yr | 120.4%
97th
|
35.9%
94th
|
— |
| Operating income CAGR, 3 yr | 163.5%
100th
|
39.3%
95th
|
— |
| Net income growth (TTM YoY) | 122.7%
76th
|
102.1%
68th
|
895.1%
98th
|
| Net income CAGR, 3 yr | 165.3%
100th
|
40.1%
90th
|
— |
| EPS growth (TTM YoY) | 125.0%
78th
|
101.0%
68th
|
876.0%
98th
|
| EPS CAGR, 3 yr | 167.9%
100th
|
33.9%
90th
|
— |
| EPS CAGR, 5 yr | 95.3%
100th
|
40.9%
90th
|
70.4%
98th
|
| FCF growth (TTM YoY) | 76.3%
78th
|
58.1%
74th
|
492.5%
96th
|
| FCF CAGR, 3 yr | 130.9%
98th
|
31.4%
85th
|
— |
| Operating cash flow CAGR, 3 yr | 124.3%
96th
|
31.6%
84th
|
286.0%
100th
|
| Book value CAGR, 3 yr | 104.6%
99th
|
58.0%
93rd
|
44.1%
91st
|
| Dividend CAGR, 3 yr | 92.5%
93rd
|
-0.9%
15th
|
3.7%
59th
|
| Sustainable growth rate | 113.1%
100th
|
30.3%
87th
|
87.6%
98th
|
Margin history & stability
7 measures| Measure | NVDA | AVGO | MU |
|---|---|---|---|
| Gross margin, 3-yr average | 73.5%
92nd
|
66.3%
89th
|
47.6%
51st
|
| Operating margin, 3-yr average | 61.7%
99th
|
38.0%
96th
|
35.5%
93rd
|
| Net margin, 3-yr average | 57.0%
99th
|
28.5%
89th
|
29.9%
92nd
|
| FCF margin, 3-yr average | 44.7%
99th
|
41.9%
97th
|
21.4%
73rd
|
| Revenue stability (0-1) | 0.81
69th
|
0.86
75th
|
0.46
39th
|
| Earnings stability (0-1) | 0.79
86th
|
0.60
75th
|
0.41
57th
|
| Margin stability (0-1) | 0.92
46th
|
0.95
62nd
|
0.05
6th
|
Liquidity (latest quarter)
7 measures| Measure | NVDA | AVGO | MU |
|---|---|---|---|
| Cash & short-term investments | $99.4B
100th
|
$24.0B
96th
|
$43.4B
99th
|
| Net cash (− = net debt) | $60.5B
100th
|
−$35.4B
0th
|
$38.3B
99th
|
| Working capital | $154.4B
100th
|
$31.3B
97th
|
$63.6B
99th
|
| Current ratio | 4.59
61st
|
2.50
28th
|
3.31
47th
|
| Quick ratio | 3.85
67th
|
2.29
43rd
|
2.94
57th
|
| Cash ratio (cash + ST investments / current liabilities) | 2.31
63rd
|
1.15
35th
|
1.58
49th
|
| Defensive interval (days) | 2,068 days
85th
|
778 days
51st
|
3,826 days
96th
|
Leverage & solvency (latest quarter)
13 measures| Measure | NVDA | AVGO | MU |
|---|---|---|---|
| Total debt | $38.9B
97th
|
$59.4B
100th
|
$5.2B
84th
|
| Debt / equity | 0.17
49th
|
0.60
76th
|
0.04
27th
|
| Net debt / equity | −0.26
44th
|
0.36
85th
|
−0.28
41st
|
| Debt / assets | 12.1%
51st
|
31.6%
76th
|
2.6%
23rd
|
| Debt / capital | 14.5%
49th
|
37.3%
76th
|
3.6%
27th
|
| Debt / EBITDA | 0.17
18th
|
1.14
50th
|
0.05
11th
|
| Net debt / EBITDA | −0.26
61st
|
0.68
79th
|
−0.35
57th
|
| Interest coverage (EBIT / interest) | 497.2x
89th
|
14.2x
56th
|
942.5x
96th
|
| Cash interest coverage | 290.2x
89th
|
13.3x
44th
|
846.0x
94th
|
| Debt payback (years of OCF) | 0.3 yrs
31st
|
1.5 yrs
53rd
|
0.1 yrs
12th
|
| Liabilities / assets | 28.5%
43rd
|
47.0%
71st
|
29.4%
45th
|
| IS credit model rating | AA+ | AA- | AA+ |
| Implied credit spread (bps) | 65
0th
|
100
39th
|
65
0th
|
Efficiency
11 measures| Measure | NVDA | AVGO | MU |
|---|---|---|---|
| Asset turnover | 1.31
100th
|
0.50
43rd
|
0.96
93rd
|
| Fixed asset turnover | 15.40
97th
|
28.34
100th
|
2.10
20th
|
| Inventory turnover | 3.3
76th
|
8.5
97th
|
2.7
56th
|
| Receivables turnover | 6.7
56th
|
8.8
79th
|
6.8
60th
|
| Days sales outstanding | 55 days
44th
|
41 days
21st
|
53 days
40th
|
| Days inventory outstanding | 111 days
24th
|
43 days
3rd
|
133 days
44th
|
| Days payables outstanding | 57 days
68th
|
35 days
15th
|
47 days
43rd
|
| Cash conversion cycle (days) | 108 days
33rd
|
50 days
7th
|
139 days
56th
|
| Capex / revenue | 2.4%
24th
|
1.4%
8th
|
27.6%
97th
|
| Capex / depreciation | 1.99
82nd
|
0.14
4th
|
3.87
92nd
|
| Operating expense ratio | 8.7%
3rd
|
14.9%
11th
|
5.0%
0th
|
Cash flow & earnings quality
7 measures| Measure | NVDA | AVGO | MU |
|---|---|---|---|
| Operating cash flow / net income | 0.70
12th
|
1.06
40th
|
1.06
38th
|
| FCF / net income | 0.66
23rd
|
1.03
58th
|
0.62
19th
|
| FCF / operating cash flow | 94.5%
95th
|
96.9%
100th
|
59.0%
26th
|
| Capex / operating cash flow | 5.5%
5th
|
3.1%
0th
|
41.0%
74th
|
| Accruals ratio | 25.4%
97th
|
-1.4%
65th
|
-3.4%
55th
|
| Sloan accruals ratio | 31.6%
85th
|
8.1%
64th
|
26.3%
80th
|
| Earnings quality score (0-1) | 0.50
12th
|
1.00
77th
|
1.00
77th
|
Scores & forensic checks
15 measures| Measure | NVDA | AVGO | MU |
|---|---|---|---|
| IS score | 84
99th
|
83
97th
|
89
100th
|
| IS profitability | 100
96th
|
100
96th
|
100
96th
|
| IS growth | 90
100th
|
81
86th
|
86
92nd
|
| IS value | 53
88th
|
36
51st
|
71
97th
|
| IS momentum | 82
58th
|
94
84th
|
94
79th
|
| IS risk (safety) | 100
12th
|
100
12th
|
100
12th
|
| IS quality | 83
81st
|
90
96th
|
94
100th
|
| IS balance sheet | 94
83rd
|
76
35th
|
98
100th
|
| IS earnings quality | 24
7th
|
77
89th
|
63
45th
|
| IS cash flow | 86
89th
|
86
88th
|
87
91st
|
| Piotroski F-score (0-9) | 7
65th
|
8
91st
|
8
91st
|
| Altman Z-score | 37.9
88th
|
14.5
59th
|
15.2
61st
|
| Beneish M-score | −0.08
95th
|
−1.60
81st
|
1.29
97th
|
| Ohlson O-score | −15.38
1st
|
−10.76
24th
|
−14.88
3rd
|
| IS credit score | 91
83rd
|
81
56th
|
91
83rd
|
Size (TTM)
8 measures| Measure | NVDA | AVGO | MU |
|---|---|---|---|
| Market cap | $5.16T
100th
|
$1.57T
99th
|
$994.3B
97th
|
| Revenue | $303.0B
100th
|
$89.1B
97th
|
$133.2B
99th
|
| EBITDA | $233.9B
100th
|
$52.3B
97th
|
$109.4B
99th
|
| Net income | $192.9B
100th
|
$38.3B
97th
|
$85.0B
99th
|
| Free cash flow | $127.0B
100th
|
$39.4B
97th
|
$52.9B
99th
|
| Total assets | $320.3B
100th
|
$188.1B
96th
|
$195.9B
97th
|
| Shareholders' equity | $229.0B
100th
|
$99.7B
97th
|
$138.4B
99th
|
| Employees | 42,000
93rd
|
33,000
89th
|
61,000
97th
|
Price performance
9 measures| Measure | NVDA | AVGO | MU |
|---|---|---|---|
| 1 day | −1.4% | −4.5% | −5.6% |
| 1 week | −6.6% | −9.1% | −14.6% |
| 1 month | −2.4% | −5.2% | −10.1% |
| 3 months | +5.5% | −13.1% | +1.6% |
| 6 months | +6.4% | −19.1% | +93.1% |
| Year to date | +13.7% | −5.4% | +178.6% |
| 1 year | +19.4% | −6.4% | +357.9% |
| 3 years, cumulative | +358.7% | +283.9% | +1,162.5% |
| 5 years, cumulative | +933.5% | +620.5% | +1,182.2% |
Technicals
4 measures| Measure | NVDA | AVGO | MU |
|---|---|---|---|
| RSI 14 | 37.6 | 34.8 | 34.0 |
| From 52-week high | −12.0% | −33.6% | −30.0% |
| From 52-week low | +30.6% | +13.4% | +356.8% |
| Beta | 2.22 | 1.48 | 2.23 |
InsiderStreet reports findings from filings and market data. A comparison is not a recommendation to buy or sell either stock.Every figure is computed in code · data as of 2026-10-17